GOLDMAN SACHS GROUP INC

Position in ARVN — Arvinas, Inc.

CIK 886982 NEW YORK, NY

Back to ARVN Full portfolio

Position in ARVN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$5,325,139

-$2,697,735 QoQ

Shares Held

640,811

-15.3% QoQ

Ownership

0.980%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#19

of 198 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 99% Shared 0% None 1%

Common Shares in ARVN Over Time

Shares Held

Position Value (USD)

Derivatives in ARVN

reported options exposure · as of Jun 30, 2021

CallValue

$770,000

CallShares

10,000

PutValue

$770,000

PutShares

10,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. ARVN ranks #191 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,481,761	$1,232,765,138
2	REGN	Regeneron Pharmaceuticals, Inc.	1,163,191	$725,296,113
3	ROIV	Roivant Sciences Ltd.	18,556,458	$656,713,046
4	TECH	BIO-TECHNE Corp	7,343,324	$518,805,838
5	RVMD	Revolution Medicines, Inc.	2,133,101	$399,487,154
6	MRNA	Moderna, Inc.	4,671,950	$327,176,656
7	TNGX	Tango Therapeutics, Inc.	9,980,620	$311,994,180
8	INCY	Incyte Corp	2,305,782	$261,383,446

All Filings in ARVN

Export CSV

34 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,325,139	640,811	-15.3%	Shares	Defined	2026-08-14
2026-03-31	$8,022,874	756,875	-32.2%	Shares	Defined	2026-05-15
2025-12-31	$13,237,538	1,116,150	+51.5%	Shares	Defined	2026-03-25
2025-09-30	$6,275,516	736,563	-10.8%	Shares	Defined	2025-11-14
2025-06-30	$6,077,061	825,688	+97.6%	Shares	Defined	2025-08-14
2025-03-31	$2,933,348	417,856	-15.2%	Shares	Defined	2025-06-27
2024-12-31	$9,447,703	492,838	-34.6%	Shares	Defined	2025-02-11
2024-09-30	$18,574,122	754,126	+26.9%	Shares	Defined	2024-11-14
2024-06-30	$15,823,593	594,425	+0.0%	Shares	Defined	2024-08-13
2024-03-31	$24,536,955	594,403	+80.4%	Shares	Defined	2024-05-15
2023-12-31	$13,560,531	329,459	+69.3%	Shares	Defined	2024-05-14
2023-09-30	$3,822,925	194,650	-28.7%	Shares	Defined	2024-05-15
2023-06-30	$6,772,881	272,880	-8.2%	Shares	Defined	2024-05-14
2023-03-31	$8,117,209	297,116	-22.1%	Shares	Defined	2024-05-14
2022-12-31	$13,042,630	381,252	-35.2%	Shares	Defined	2024-05-14
2022-09-30	$26,183,610	588,528	+56.9%	Shares	Defined	2024-05-14
2022-06-30	$15,785,937	375,052	+43.6%	Shares	Defined	2024-05-14
2022-03-31	$17,575,057	261,145	-6.8%	Shares	Defined	2022-05-16
2021-12-31	$23,014,805	280,190	-24.7%	Shares	Defined	2022-02-17
2021-09-30	$30,587,149	372,197	+48.2%	Shares	Defined	2022-01-20
2021-06-30	$19,332,852	251,076	-34.4%	Shares	Defined	2021-08-13
2021-06-30	$770,000	10,000	0.0%	Put	Defined	2021-08-13
2021-06-30	$770,000	10,000	0.0%	Call	Defined	2021-08-13
2021-03-31	$661,000	10,000	-56.7%	Put	Defined	2021-05-17
2021-03-31	$25,286,554	382,550	-22.8%	Shares	Defined	2021-05-17
2021-03-31	$661,000	10,000	-88.0%	Call	Defined	2021-05-17
2020-12-31	$1,961,883	23,100	—	Put	Defined	2021-02-12
2020-12-31	$42,063,196	495,269	+22.7%	Shares	Defined	2021-02-12
2020-12-31	$7,057,683	83,100	+99.3%	Call	Defined	2021-02-12
2020-09-30	$984,537	41,700	+66.8%	Call	Defined	2020-11-13
2020-09-30	$9,531,946	403,725	+79.5%	Shares	Defined	2020-11-13
2020-06-30	$838,500	25,000	—	Call	Defined	2020-08-12
2020-06-30	$7,544,520	224,941	+0.8%	Shares	Defined	2020-08-12
2020-03-31	$8,990,042	223,078	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.